StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
SRNE opened at $0.00 on Thursday. Sorrento Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.25. The business has a 50 day moving average of $0.01 and a 200-day moving average of $0.01.
Sorrento Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- What Makes a Stock a Good Dividend Stock?
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- 3 Fintech Stocks With Good 2021 Prospects
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- 3 REITs to Buy and Hold for the Long Term
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.